3-Bromo-1-(3-chloro­pyridin-2-yl)-N-(4-eth­oxy­phen­yl)-1H-pyrazole-5-carbox­amide

por Yue, Hai, Dong, Wei-Li, Wang, Run-Ling, Cheng, Xian-Chao
Publicado 2010

3-Hy­droxy­methyl-1-(4-meth­oxy­phen­yl)imidazolidine-2,4-dione

por Cheng, Xian-Chao, Hou, Jing-Jing, Wang, Run-Ling, Dong, Wei-Li
Publicado 2010

Methyl 3-(cyclo­propyl­meth­oxy)-4-hy­droxy­benzoate

por Hou, Jing-Jing, Cheng, Xian-Chao, Wang, Run-Ling, Wang, Shu-Qing
Publicado 2010

Methyl 3-(cyclo­propyl­meth­oxy)-4-hy­droxy­benzoate. Corrigendum

por Hou, Jing-Jing, Cheng, Xian-Chao, Wang, Run-Ling, Wang, Shu-Qing
Publicado 2010

Ethyl 4-[(4-chloro­phen­oxy)meth­yl]-2-(4-nitro­phen­yl)-1,3-thia­zole-5-carboxyl­ate

por Deng, Zhi-Rong, Wang, Shu-Qing, Dong, Wei-Li, Wang, Run-Ling
Publicado 2011

Poly[[bis­(μ-4,4′-bipyridine-κ(2) N:N′)copper(I)] perchlorate 0.24-hydrate]

por Zhang, Chun-Yan, Yao, Xue-Jun, Wang, Run-Ling, Xie, Cheng-Zhi
Publicado 2012

1-(4-Methoxy­phen­yl)imidazolidine-2,4-dione

por Sun, Su-Xia, Zhang, Hao, Cheng, Xian-Chao, Wang, Run-Ling, Dong, Wei-Li
Publicado 2010

Design Novel Dual Agonists for Treating Type-2 Diabetes by Targeting Peroxisome Proliferator-Activated Receptors with Core Hopping Approach

por Ma, Ying, Wang, Shu-Qing, Xu, Wei-Ren, Wang, Run-Ling, Chou, Kuo-Chen
Publicado 2012

Methyl 3,4-bis­(cyclo­propyl­meth­oxy)benzoate

por Cheng, Xian-Chao, Hou, Jing-Jing, Xie, Cheng-Zhi, Wang, Run-Ling, Xu, Wei-Ren
Publicado 2011

Novel Inhibitor Design for Hemagglutinin against H1N1 Influenza Virus by Core Hopping Method

por Li, Xiao-Bo, Wang, Shu-Qing, Xu, Wei-Ren, Wang, Run-Ling, Chou, Kuo-Chen
Publicado 2011

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors

por Zhang, Li-Song, Wang, Shu-Qing, Xu, Wei-Ren, Wang, Run-Ling, Wang, Jing-Fang
Publicado 2012

Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics

por Liu, Lei, Ma, Ying, Wang, Run-Ling, Xu, Wei-Ren, Wang, Shu-Qing, Chou, Kuo-Chen
Publicado 2013

Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone

por Wang, Xue-Jiao, Zhang, Jun, Wang, Shu-Qing, Xu, Wei-Ren, Cheng, Xian-Chao, Wang, Run-Ling
Publicado 2014

The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approaches

por Li, Hong-Lian, Ma, Ying, Ma, Ying, Li, Yu, Chen, Xiu-Bo, Dong, Wei-Li, Wang, Run-Ling
Publicado 2017

Design, Synthesis, Biological Activity and Molecular Dynamics Studies of Specific Protein Tyrosine Phosphatase 1B Inhibitors over SHP-2

por Sun, Su-Xia, Li, Xiao-Bo, Liu, Wen-Bo, Ma, Ying, Wang, Run-Ling, Cheng, Xian-Chao, Wang, Shu-Qing, Liu, Wei
Publicado 2013

Synthesis, bioactivity, 3D-QSAR studies of novel dibenzofuran derivatives as PTP-MEG2 inhibitors

por Ma, Ying, Wei, Hui-Yu, Zhang, Yu-Ze, Jin, Wen-Yan, Li, Hong-Lian, Zhou, Hui, Cheng, Xian-Chao, Wang, Run-Ling
Publicado 2017

Molecular docking, 3D-QSAR and structural optimization on imidazo-pyridine derivatives dually targeting AT1 and PPARγ

por Zhang, Jun, Hao, Qing-Qing, Liu, Xin, Jing, Zhi, Jia, Wen-Qing, Wang, Shu-Qing, Xu, Wei-Ren, Cheng, Xian-Chao, Wang, Run-Ling
Publicado 2017

Design, sythesis and evaluation of a series of 3- or 4-alkoxy substituted phenoxy derivatives as PPARs agonists

por Zhang, Jun, Wang, Xue-Jiao, Liu, Xin, Huan, Yi, Yang, Miao-Miao, Shen, Zhu-Fang, Jia, Wen-Qing, Jing, Zhi, Wang, Shu-Qing, Xu, Wei-Ren, Cheng, Xian-Chao, Wang, Run-Ling
Publicado 2017